- Home
- CRBP vs MAPS Comparison
CRBP vs MAPS Comparison
Compare CRBP & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- MAPS
- Stock Information
- Founded
- CRBP 2009
- MAPS 2008
- Country
- CRBP United States
- MAPS United States
- Employees
- CRBP N/A
- MAPS N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- MAPS Computer Software: Prepackaged Software
- Sector
- CRBP Health Care
- MAPS Technology
- Exchange
- CRBP Nasdaq
- MAPS Nasdaq
- Market Cap
- CRBP 143.7M
- MAPS 134.9M
- IPO Year
- CRBP N/A
- MAPS N/A
- Fundamental
- Price
- CRBP $11.93
- MAPS $1.40
- Analyst Decision
- CRBP Strong Buy
- MAPS Strong Buy
- Analyst Count
- CRBP 8
- MAPS 1
- Target Price
- CRBP $62.00
- MAPS $2.61
- AVG Volume (30 Days)
- CRBP 256.8K
- MAPS 1.3M
- Earning Date
- CRBP 03-11-2025
- MAPS 11-12-2024
- Dividend Yield
- CRBP N/A
- MAPS N/A
- EPS Growth
- CRBP N/A
- MAPS N/A
- EPS
- CRBP N/A
- MAPS N/A
- Revenue
- CRBP N/A
- MAPS $183,311,000.00
- Revenue This Year
- CRBP N/A
- MAPS N/A
- Revenue Next Year
- CRBP N/A
- MAPS $7.86
- P/E Ratio
- CRBP N/A
- MAPS N/A
- Revenue Growth
- CRBP N/A
- MAPS N/A
- 52 Week Low
- CRBP $7.30
- MAPS $0.70
- 52 Week High
- CRBP $61.90
- MAPS $1.65
- Technical
- Relative Strength Index (RSI)
- CRBP 39.08
- MAPS 53.72
- Support Level
- CRBP $11.02
- MAPS $1.26
- Resistance Level
- CRBP $13.28
- MAPS $1.52
- Average True Range (ATR)
- CRBP 0.74
- MAPS 0.10
- MACD
- CRBP 0.16
- MAPS -0.02
- Stochastic Oscillator
- CRBP 40.27
- MAPS 51.85
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.